FDA staff sends mixed message on JJ drug Xarelto
WASHINGTON (Reuters) - U.S. drug reviewers had mixed opinions about whether Johnson Johnson blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart problems, setting the stage for heated debate by outside experts later this week. (Source: Reuters: Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div

Panel: Don't Get PSA Prostate Cancer Screen
The USPSTF, the independent panel that sets U.S. policy on cancer screening, has finalized its draft guideline finding that men get more harm than benefit from routine PSA tests for prostate cancer. (Source: WebMD Health)